UBE2S promotes cancer stemness through diverse mechanisms: enhancing p53 ubiquitination to facilitate proliferation and migration, accelerating cell cycle progression via p27 ubiquitination, and inducing chemoresistance through both the PTEN/AKT and Wnt/β-catenin signaling pathways (53). Here, AKT1 is linked to cancer.